InMed Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	6.95	11.08	6.57	8.91	6.18	7.36
Short-Term Investments	0.04	0.04	0.04	0.04	0.04	0.05
Cash & Short-Term Investments	7	11.12	6.61	8.96	6.22	7.41
Cash Growth	102.23%	68.10%	-26.15%	43.96%	-16.03%	26.70%
Accounts Receivable	0.18	0.47	0.35	0.26	0.09	-
Other Receivables	-	-	-	-	-	0.01
Receivables	0.18	0.47	0.35	0.26	0.09	0.01
Inventory	0.95	0.96	1.24	1.62	2.49	-
Prepaid Expenses	0.66	0.32	0.48	0.5	0.8	0.84
Other Current Assets	-	-	-	-	-	0.11
Total Current Assets	8.79	12.87	8.69	11.33	9.6	8.38
Property, Plant & Equipment	0.76	0.99	1.25	0.72	0.9	0.33
Other Intangible Assets	1.54	1.62	1.78	1.95	2.11	1.06
Other Long-Term Assets	0.1	0.1	0.1	0.1	0.18	0.01
Total Assets	11.19	15.58	11.82	14.11	12.79	9.78
Accounts Payable	0.17	0.37	0.63	0.54	1.17	0.78
Accrued Expenses	0.7	1.03	0.99	1.06	1.25	1.36
Current Portion of Leases	0.41	0.44	0.32	0.38	0.4	0.08
Other Current Liabilities	0.21	0	0.04	0.02	0.5	-
Total Current Liabilities	1.48	1.84	1.97	2	3.32	2.22
Long-Term Leases	0.12	0.31	0.64	0.02	0.39	0.19
Total Liabilities	1.6	2.15	2.62	2.02	3.71	2.4
Common Stock	92.05	91.22	82.78	77.62	70.72	60.59
Additional Paid-In Capital	38.41	39.32	35.37	35.74	31.68	21.51
Retained Earnings	-120.99	-117.24	-109.08	-101.4	-93.45	-74.85
Comprehensive Income & Other	0.13	0.13	0.13	0.13	0.13	0.13
Shareholders' Equity	9.59	13.43	9.21	12.09	9.08	7.38
Total Liabilities & Equity	11.19	15.58	11.82	14.11	12.79	9.78
Total Debt	0.53	0.74	0.96	0.39	0.79	0.27
Net Cash (Debt)	6.47	10.38	5.65	8.57	5.43	7.14
Net Cash Growth	157.46%	83.62%	-34.01%	57.80%	-23.98%	29.08%
Net Cash Per Share	2.47	10.63	14.83	69.96	193.57	531.24
Filing Date Shares Outstanding	2.92	2.38	0.67	0.17	0.05	0.02
Total Common Shares Outstanding	2.8	2	0.45	0.17	0.03	0.02
Working Capital	7.31	11.03	6.72	9.33	6.28	6.16
Book Value Per Share	3.42	6.71	20.64	72.65	279.06	458.14
Tangible Book Value	8.05	11.81	7.42	10.14	6.97	6.31
Tangible Book Value Per Share	2.87	5.90	16.65	60.95	214.23	392.20
Machinery	-	0.43	0.47	0.48	0.25	0.07
Leasehold Improvements	-	-	-	-	-	0.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.